AKT1 and Hepatic steatosis: In accordance with previous findings,31 overexpression of myr-AKT1 (n=6) led to hepatic steatosis and, eventually, the development of multiple hepatocellular carcinomas (HCC) in each mouse by 28 weeks post-injection (data not shown).